Streetbeat News

Price Targets

TPVG

JMP Securities analyst Devin Ryan maintains a Market Outperform rating on TriplePoint Venture Growth (NYSE:TPVG) but lowers the price target from $13.5 to $11.5.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 10:27 am

WPM

RBC Capital analyst Josh Wolfson downgraded Wheaton Precious Metals (NYSE:WPM) from Outperform to Sector Perform and announced a $45 price target.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 10:26 am

ZM

MoffettNathanson analyst Sterling Auty upgraded Zoom Video Comms (NASDAQ:ZM) from Underperform to Market Perform and announced an $85 price target.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 10:24 am

CCCS

Evercore ISI Group analyst Kirk Materne has upgraded CCC Intelligent Solutions (NASDAQ:CCCS) from In-Line to Outperform, with a new price target of $13.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 10:23 am

CVX

HSBC analyst Gordon Gray has upgraded Chevron (NYSE:CVX) from Hold to Buy, announcing a $189 price target.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 10:21 am

STGW

Needham analyst Laura Martin reiterated a Buy rating on Stagwell (NASDAQ:STGW) and maintained an $8 price target.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 10:19 am

ANIX

HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on Anixa Biosciences (NASDAQ:ANIX) and maintained a $12 price target.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 10:17 am

SAGE

HC Wainwright & Co. analyst Douglas Tsao reiterated a Neutral rating on Sage Therapeutics (NASDAQ:SAGE) and maintained a $50 price target.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 10:16 am

ICCM

HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on Icecure Medical (NASDAQ:ICCM) and maintained a $3 price target.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 10:15 am

BNTX

HC Wainwright & Co. analyst Robert Burns maintains a Buy rating on BioNTech (NASDAQ:BNTX) but lowers the price target from $210 to $198.

Portfolio Pulse from richadhand@benzinga.com

May 23, 2023 | 10:13 am